目的 探讨MRI联合血清肿瘤标 志物用于临床诊断子宫内膜癌患者的价 值。方法 收集我院2014年3月-2016年11 月90例经手术组织病理学确诊为I-II期 子宫内膜癌患者为此次研究对象，对比 MRI联合血清肿瘤标志物与单独运用MRI 检查对子宫内膜癌患者诊断效能差别。 结果 单纯MRI检查敏感度为84.96%、 特异度为70.68%，MRI联合血清肿瘤标 志物检查敏感度为86.72%、特异度为 79.92%，两组间比较，P<0.05；MRI联合 血清肿瘤标志物检查的敏感度明显高于 单纯MRI检查，P<0.05。结论 联合MRI与 血清肿瘤标志物有助提高对早期子宫内 膜癌的诊断率，从而可为临床及时治疗 与正确选择治疗方案提供参考。

Objective To explore the value of MRI combined with serum tumor markers in the clinical diagnosis of endometrial cancer. Methods A total of 90 patients with stage I~II endometrial carcinoma diagnosed by surgical histopathology in November 2016 to March 2014 were collected as the research objects，and com-pare the diagnostic efficacy of MRI combined with serum tumor markers (serum CA125, OPN and CA199) and MRI examination alone in patients with endometrial cancer. Results The diagnostic sensitivity of simple MRI examination was 84.96%, and the specificity was 70.68%. The diagnostic sensitivity of MRI combined with se-rum tumor markers was 86.72%, and the specificity was 79.92%, P<0.05, significantly higher than that of simple MRI examination (P<0.05). Conclusion The combination of MRI and serum tumor markers helps to improve the diagnostic rate of early endo-metrial cancer, which can provide a reference for clinical timely treatment and the correct choice of treatment programs，and it can provide reference for the timely treatment and the correct choice of the treatment plan.